| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 05/23/2012 | CN101948539B IL-18 binding proteins |
| 05/22/2012 | CA2614667C 20-keto-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 05/22/2012 | CA2532089C Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
| 05/18/2012 | WO2012064928A1 Methods and compositions for treating thyroid hormone related disorders |
| 05/18/2012 | WO2012064631A1 Pyridyl ureas as mineralocorticoid receptor antagonists |
| 05/18/2012 | WO2012062697A1 Combination therapy for type 1 diabetes |
| 05/18/2012 | WO2012061931A1 Use of geniposide in diabetes prevention |
| 05/18/2012 | WO2011154975A3 Pharmaceutical compositions of metformin |
| 05/17/2012 | US20120122941 Cycloalkylamine derivatives |
| 05/17/2012 | US20120122921 Process for making modulators of cystic fibrosis transmembrane conductance regulator |
| 05/17/2012 | US20120122912 Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 05/17/2012 | US20120122894 Inhibitors of bruton's tyrosine kinase |
| 05/17/2012 | US20120122891 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 05/17/2012 | US20120122829 Pharmaceutical composition for transdermal or transmucous administration |
| 05/17/2012 | US20120122782 Complexation of metal ions with polypeptides |
| 05/17/2012 | US20120122780 Compounds, Compositions and Methods for Modulating Uric Acid Levels |
| 05/17/2012 | US20120122779 Method for site-specific polyvalent display on polymers |
| 05/17/2012 | US20120122764 Substituted carbamoylcycloalkyl acetic acid derivatives as nep |
| 05/17/2012 | US20120122763 Novel tetrahydrocarbazole derivatives as ligands of g-protein coupled receptors |
| 05/17/2012 | US20120122762 186 Human Secreted Proteins |
| 05/17/2012 | US20120121602 Novel proteins |
| 05/17/2012 | US20120121554 Hmg-coa secondary metabolites and uses thereof |
| 05/16/2012 | EP2453009A1 Methods of organ regeneration |
| 05/16/2012 | EP2451779A2 Etomidate analogues that do not inhibit adrenocortical steroid synthesis |
| 05/16/2012 | EP2451469A2 Composition for the treatment of benign prostate hyperplasia |
| 05/16/2012 | EP2451299A1 Methods and compositions for treating thyroid-related medical conditions with reduced folates |
| 05/16/2012 | EP2224945B1 Methods of enhancing diabetes resolution |
| 05/16/2012 | EP1888615B1 17 -hsd1 and sts inhibitors |
| 05/16/2012 | CN1575338B Bv8 nucleic acids and polypeptides with mitogenic activity |
| 05/16/2012 | CN102459304A 用于女性保健的取代16,17-稠合的类固醇化合物 Health care for women replace 16,17 fused steroid compound |
| 05/16/2012 | CN102459247A 作为醛固酮合酶抑制剂的苯并噁唑酮衍生物 As aldosterone synthase inhibitors benzoxazole derivatives |
| 05/16/2012 | CN102459221A 噻吩衍生物 Thiophene derivative |
| 05/16/2012 | CN102459185A 新型甲状腺激素β受体激动剂 Novel thyroid hormone receptor β agonists |
| 05/16/2012 | CN102458386A 用于紧急避孕的药物组合物 Pharmaceutical compositions for emergency contraception |
| 05/16/2012 | CN102451411A Preparation method of traditional Chinese medicine prescription for treating hyperthyroidism |
| 05/16/2012 | CN102451337A Preparation method for Chinese herbal prescription used for treating hypofunction of anterior pituitary |
| 05/16/2012 | CN101934015B Traditional Chinese medicinal composition for treating thyroid and method for preparing dispelling-goitre cataplasm thereof |
| 05/16/2012 | CN101228127B Novel piperidine derivative |
| 05/15/2012 | US8178651 Somatostatin-dopamine chimeric analogs |
| 05/15/2012 | CA2650297C Hydroxymatairesinol in cancer prevention |
| 05/15/2012 | CA2496329C Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 05/10/2012 | WO2012059594A1 Mineralcorticoid receptor antagonists for the treatment of corticoid-induced obesity |
| 05/10/2012 | US20120115939 Methods for using lipoic acid |
| 05/10/2012 | US20120115933 Organic Compositions to Treat Beta-ENaC-Related Diseases |
| 05/10/2012 | US20120115931 Selective inhibitors of cb2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders |
| 05/10/2012 | US20120115907 Novel compounds as inhibitors of renin |
| 05/10/2012 | US20120115858 Polymorph Form II of Tanaproget |
| 05/10/2012 | US20120115854 Pharmaceutical composition containing antihypertensive agents |
| 05/10/2012 | US20120115851 Compound inhibiting in vivo phosphorus transport and medicine containing the same |
| 05/10/2012 | US20120115823 Bismuth-containing compounds, coordination polymers, methods for modulating pharmacokinetic properties of biologically active agents, and methods for treating patients |
| 05/10/2012 | US20120115802 Method for using ulipristal acetate with cytochrome isozyme modulators |
| 05/10/2012 | US20120114775 Methods for the treatment or prevention of diabetes mellitus and other metabolic imbalances |
| 05/10/2012 | US20120114773 ESTROGENIC EXTRACTS OF Ligustrum lucidum Ait. of the Oleaceae Family AND USES THEREOF |
| 05/10/2012 | US20120114757 Particles comprising drospirenone encapsulated in a polymer |
| 05/10/2012 | US20120114748 Tanaproget Compositions Containing Ethinyl Estradiol |
| 05/10/2012 | US20120114737 Silicone acrylate hybrid composition and method of making same |
| 05/10/2012 | US20120114730 Compositions and methods for treating precocious puberty |
| 05/10/2012 | US20120114716 Flowable Carrier Matrix |
| 05/10/2012 | US20120114706 Endorphin Therapy Compositions and Methods of Use Thereof |
| 05/10/2012 | US20120114667 TARGETED BINDING AGENTS DIRECTED TO a5BETA1 AND USES THEREOF |
| 05/10/2012 | US20120114556 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 05/09/2012 | EP1644342B1 Arylpyrimidines useful for the treatment of sex hormone-related conditions such as endometriosis, prostate cancer and the like |
| 05/09/2012 | EP1427830B1 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY |
| 05/09/2012 | EP1284963B1 Novel calcium receptor active molecules and method for preparing same |
| 05/09/2012 | EP1140201B1 Compounds for intracellular delivery of therapeutic moieties to nerve cells |
| 05/09/2012 | CN102448978A Novel Glucocorticoid Receptor Agonists |
| 05/09/2012 | CN102448466A New therapeutical uses of inecalcitol |
| 05/09/2012 | CN102448464A Improved glucocorticoid therapy |
| 05/09/2012 | CN102441110A Traditional Chinese medicinal composition for auxiliary treatment of hyperthyroidism |
| 05/09/2012 | CN102441109A Traditional Chinese medicinal composition for adjuvant treatment of hyperthyroidism |
| 05/09/2012 | CN102441099A Traditional Chinese medicine for treating goiter |
| 05/09/2012 | CN102440966A Preparation process research of exenatide slow-release preparation |
| 05/09/2012 | CN102166327B Preparation method of Chinese medicine for treating liver-stagnation spleen-deficiency hyperthyroidism |
| 05/09/2012 | CN102166309B Preparation method of traditional Chinese medicine for curing middle energizer intrinsic heat type hyperthyroidism |
| 05/09/2012 | CN102028751B Chinese medicinal composition serving as phytoestrogen and application thereof |
| 05/09/2012 | CN101332229B Prunella plant extract and pharmaceutical use thereof |
| 05/09/2012 | CN101098674B Use of a complex nutritional base in cosmetics, in particular for the hair |
| 05/08/2012 | US8173782 Fusion protein comprising growth hormone and growth hormone receptor |
| 05/08/2012 | US8173615 TRPM-2 antisense therapy |
| 05/08/2012 | US8173592 Method for a programmed controlled ovarian stimulation protocol |
| 05/08/2012 | US8173129 Methods and compositions for treating autoimmune diseases |
| 05/08/2012 | CA2631841C Fast-acting oral peptide pharmaceutical products |
| 05/08/2012 | CA2531905C Specific glucocorticosteroid compound having anti-inflammatory activity |
| 05/08/2012 | CA2353574C Analogues of glp-1 |
| 05/03/2012 | WO2012055840A1 Composition and preparation for treatment of dysmenorrhea and menstrual pain and use of a hormonal agent and a zinc salt for treatment of menstrual disorders |
| 05/03/2012 | WO2012031342A3 Polymer system and method for encapsulating human amylin and agonist analogues, and use thereof; released amylin functional evaluation method |
| 05/03/2012 | US20120108603 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 05/03/2012 | US20120108599 Methods and compositions for the treatment of metabolic disorders |
| 05/03/2012 | US20120108571 Substituted phenoxy n-alkylated thiazolidinediones as estrogen related receptor-alpha modulators |
| 05/03/2012 | US20120108512 Stable pharmaceutical compositions of peptide derivatized using an oxime linker |
| 05/03/2012 | US20120108505 Thiophenes as glucagon receptor antagonists, compositions, and methods for their use |
| 05/03/2012 | US20120108504 Leptin agonist and methods of use |
| 05/03/2012 | US20120107846 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 05/03/2012 | US20120107426 Ghrelin production promoter |
| 05/03/2012 | US20120107371 Stimuli-responsive systems for controlled drug delivery |
| 05/03/2012 | US20120107275 Fused heterocyclic derivatives and methods of use |
| 05/02/2012 | EP2446900A1 Methods for treating conditions associated with MASP-2 dependent complement activation |
| 05/02/2012 | EP2445491A1 Pharmaceutical composition for emergency contraception |
| 05/02/2012 | EP1716851B1 Thioamides and salts thereof and cytokine production inhibitors containing both |
| 05/02/2012 | EP1534668B1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |